Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma.
Journal
HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
30
12
2022
revised:
24
05
2023
accepted:
21
06
2023
pubmed:
6
8
2023
medline:
6
8
2023
entrez:
5
8
2023
Statut:
ppublish
Résumé
Major surgery, along with preoperative cholestasis-related complications, are responsible for the increased risk of morbidity and mortality in perihilar cholangiocarcinoma (pCCA). The aim of the present survey is to provide a snapshot of current preoperative management and optimization strategies in Europe. 61 European centers, experienced in hepato-biliary surgery completed a 59-questions survey regarding pCCA preoperative management. Centers were stratified according to surgical caseload (<5 and ≥ 5 cases/year) and preoperative management protocols' application. The overall case volume consisted of 6333 patients. Multidisciplinary discussion was routinely performed in 91.8% of centers. Most respondents (96.7%) recognized the importance of a well-structured preoperative protocol. The preferred method for biliary drainage was percutaneous transhepatic biliary drainage (60.7%) while portal vein embolization was the preferred technique for liver hypertrophy (90.2%). Differences in preoperative pathologic confirmation of malignancy (35.8% vs 28.7%; p < 0.001), number of mismanaged referred patients (88.2% vs 50.8%; p < 0.001), biliary drainage (65.1% vs 55.6%; p = 0.015) and liver function evaluation (37.2% vs 5.6%; p = 0.001) were found between centers according to groups' stratification. The importance of a correct preoperative management is recognized. Nevertheless, the current lack of guidelines leads to wide heterogeneity of behaviors among centers. This survey can provide recommendations to improve pCCA perioperative outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Major surgery, along with preoperative cholestasis-related complications, are responsible for the increased risk of morbidity and mortality in perihilar cholangiocarcinoma (pCCA). The aim of the present survey is to provide a snapshot of current preoperative management and optimization strategies in Europe.
METHODS
METHODS
61 European centers, experienced in hepato-biliary surgery completed a 59-questions survey regarding pCCA preoperative management. Centers were stratified according to surgical caseload (<5 and ≥ 5 cases/year) and preoperative management protocols' application.
RESULTS
RESULTS
The overall case volume consisted of 6333 patients. Multidisciplinary discussion was routinely performed in 91.8% of centers. Most respondents (96.7%) recognized the importance of a well-structured preoperative protocol. The preferred method for biliary drainage was percutaneous transhepatic biliary drainage (60.7%) while portal vein embolization was the preferred technique for liver hypertrophy (90.2%). Differences in preoperative pathologic confirmation of malignancy (35.8% vs 28.7%; p < 0.001), number of mismanaged referred patients (88.2% vs 50.8%; p < 0.001), biliary drainage (65.1% vs 55.6%; p = 0.015) and liver function evaluation (37.2% vs 5.6%; p = 0.001) were found between centers according to groups' stratification.
CONCLUSION
CONCLUSIONS
The importance of a correct preoperative management is recognized. Nevertheless, the current lack of guidelines leads to wide heterogeneity of behaviors among centers. This survey can provide recommendations to improve pCCA perioperative outcomes.
Identifiants
pubmed: 37543473
pii: S1365-182X(23)00568-3
doi: 10.1016/j.hpb.2023.06.013
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1302-1322Investigateurs
Robert Sutcliffe
(R)
Pim Olthof
(P)
Andrea Ruzzenente
(A)
Florin Botea
(F)
Enrico Gringeri
(E)
Fabian Bartsch
(F)
Nadia Russolillo
(N)
Carlo Sposito
(C)
Matteo Serenari
(M)
Francesco Ardito
(F)
Jonathan Garnier
(J)
Asmund Fretland
(A)
Arpad Ivanecz
(A)
Olivier Scatton
(O)
Andrii Lukashenko
(A)
Santi L Ben
(SL)
Miguel A Lopez Bravo
(MA)
Ajith Siriwardena
(A)
Marc Schiesser
(M)
Elio Jovine
(E)
Bas G Koerkamp
(BG)
Olivier Soubrane
(O)
Cornelis H Dejong
(CH)
Fabrice Muscari
(F)
Andre Trudnikov
(A)
Ville Sallinen
(V)
Par Sandstrom
(P)
Giedrius Barauskas
(G)
Jiri Pudil
(J)
Bergthor Bjornsson
(B)
Lilian Schwarz
(L)
Erik Schadde
(E)
Thomas Gruenberger
(T)
Fernando Rotellar
(F)
Dervenis Christos
(D)
Vladislav Treska
(V)
David Fuks
(D)
Jan Schmidt
(J)
Fatih M Can
(FM)
Fernando P Aranda
(FP)
Michal Solecki
(M)
Informations de copyright
Copyright © 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest None to declare.